Toyama H, Li Y, Hatazawa J, Huang G, Kubota K: PET/CT for inflammatory diseases. Basic sciences, typical cases, and review Pasqualina SanninoLuigi Mansi Book Review 04 May 2021 Pages: 2665 - 2665
A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands Germo Gericke Letter to the Editor Open access 13 May 2021 Pages: 2666 - 2667
2021: the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? Ken HerrmannClemens KratochwilRoland Hustinx Editorial Open access 22 May 2021 Pages: 2668 - 2669
Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavorable intermediate and high-risk prostate cancer John CampañaPatricia Bernal Letter to the Editor 04 May 2021 Pages: 2670 - 2671
Response to the Letter to the Editor: Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer Simona MalaspinaMikael AnttinenOtto Ettala Letter to the Editor 14 June 2021 Pages: 2672 - 2673
About the source and consequences of 18F-FDG brain PET hypometabolism in short and long COVID-19 Igor C. FontanaDébora Guerini SouzaEduardo R. Zimmer Letter to the Editor 04 April 2021 Pages: 2674 - 2675
Give to Fryback what is Fryback’s, and to new PET technologies what is new PET technologies’ Paulo Schiavom Duarte Letter to the Editor 13 June 2021 Pages: 2676 - 2677
Women in nuclear medicine Ozgul EkmekciogluLaura EvangelistaJolanta Kunikowska Editorial 25 May 2021 Pages: 2678 - 2679
To go where no one has gone before: the necessity of radiobiology studies for exploration beyond the limits of the “Holy Gray” in radionuclide therapy Frederik A. VerburgJulie NonnekensMarion de Jong Editorial 04 January 2021 Pages: 2680 - 2682
ImmunoPET of CD38 with a radiolabeled nanobody: promising for clinical translation Sixiang ShiShreya GoelWeibo Cai Editorial 03 May 2021 Pages: 2683 - 2686
Molecular imaging with FLT: a case of Cassandra’s curse? Rodney J. Hicks Editorial 03 June 2021 Pages: 2687 - 2689
Comments to “Survey by the ANSM of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT” Francesco GiammarileStefano Fanti Editorial 19 March 2021 Pages: 2690 - 2691
Response to the letter to the Editor by Professors Francesco Giammarile and Stefano Fanti regarding our article “Survey by the ANSM of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT” Yanna-Marina ChevalmeLotfi BoudaliJean-Noël Talbot Letter to the Editor Open access 31 May 2021 Pages: 2692 - 2695
Moving the goalposts while scoring―the dilemma posed by new PET technologies Julian M.M. RogaschRonald BoellaardCarsten Kobe Controversies - Against Open access 14 May 2021 Pages: 2696 - 2710
New PET technologies – embracing progress and pushing the limits Nicolas AideCharline LasnonDaniel R McGowan Controversies - For Open access 03 June 2021 Pages: 2711 - 2726
Improved in vivo PET imaging of the adenosine A2A receptor in the brain using [18F]FLUDA, a deuterated radiotracer with high metabolic stability Thu Hang LaiMagali ToussaintPeter Brust Original Article Open access 02 February 2021 Pages: 2727 - 2736
ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma Miao LiWeijun WeiWeibo Cai Original Article 03 February 2021 Pages: 2737 - 2748
ImmunoPET imaging of multiple myeloma with [68Ga]Ga-NOTA-Nb1053 Cheng WangYumei ChenWeijun Wei Original Article 05 February 2021 Pages: 2749 - 2760
α-Particle-induced DNA damage tracks in peripheral blood mononuclear cells of [223Ra]RaCl2-treated prostate cancer patients S. SchumannU. EberleinH. Scherthan Original Article Open access 04 February 2021 Pages: 2761 - 2770
Artificial intelligence enables whole-body positron emission tomography scans with minimal radiation exposure Yan-Ran (Joyce) WangLucia BarattoHeike E. Daldrup-Link Original Article 01 February 2021 Pages: 2771 - 2781
Deep learning-based auto-delineation of gross tumour volumes and involved nodes in PET/CT images of head and neck cancer patients Yngve Mardal MoeAurora Rosvoll GroendahlCecilia Marie Futsaether Original Article Open access 09 February 2021 Pages: 2782 - 2792
Diagnostic accuracy of stress-only myocardial perfusion SPECT improved by deep learning Hui LiuJing WuYi-Hwa Liu Original Article 29 January 2021 Pages: 2793 - 2800
The EANM practice guidelines for parathyroid imaging Petra Petranović OvčaričekLuca GiovanellaFrederik Anton Verburg Guidelines Open access 10 April 2021 Pages: 2801 - 2822
18F-FDG brain PET hypometabolism in patients with long COVID E. GuedjJ. Y. CampionC. Eldin Original Article 26 January 2021 Pages: 2823 - 2833
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients Pietro MattioliMatteo PardiniDario Arnaldi Original Article 28 January 2021 Pages: 2834 - 2845
A first-in-human study of 11C-MTP38, a novel PET ligand for phosphodiesterase 7 Manabu KubotaChie SekiMakoto Higuchi Original Article Open access 10 February 2021 Pages: 2846 - 2855
Harmonisation of PET/CT contrast recovery performance for brain studies E. E. VerwerS. S. V. GollaR. Boellaard Original Article Open access 31 January 2021 Pages: 2856 - 2870
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study Domenico AlbanoFrancesco BertagnaOn the behalf of Italian Association of Nuclear Medicine (AIMN) Original Article Open access 09 February 2021 Pages: 2871 - 2882
18F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study Ryogo MinamimotoLuis FayadAndrew Quon Original Article Open access 28 April 2021 Pages: 2883 - 2893
Impact of EBUS-TBNA in addition to [18F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC Maja GuberinaKaid DarwicheMartin Stuschke Original Article Open access 05 February 2021 Pages: 2894 - 2903
Use of radiomics based on 18F-FDG PET/CT and machine learning methods to aid clinical decision-making in the classification of solitary pulmonary lesions: an innovative approach Yi ZhouXue-lei MaRong Tian Original Article 05 February 2021 Pages: 2904 - 2913
Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study Leigh C. CasadabanPaul J. CatalanoPaul B. Shyn Original Article 09 February 2021 Pages: 2914 - 2924
Performance of [68Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy—a multi-centre evaluation of 2533 patients Ali Afshar-OromiehMarcelo Livorsi da CunhaIsabel Rauscher Original Article Open access 04 February 2021 Pages: 2925 - 2934
Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer in case of negative or equivocal 18F-fluorocholine PET/CT: 1084 examinations Yanna-Marina ChevalmeLotfi BoudaliJean-Noël Talbot Original Article Open access 08 January 2021 Pages: 2935 - 2950
Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer Simona MalaspinaMikael AnttinenOtto Ettala Original Article Open access 13 March 2021 Pages: 2951 - 2959
Management impact of 18F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study Dennie MeijerPim J. van LeeuwenAndré N. Vis Original Article Open access 05 February 2021 Pages: 2960 - 2969
Diagnostic value of 18F-FDG PET/CT in patients with biochemical recurrent prostate cancer and negative 68Ga-PSMA PET/CT Ruohua ChenYining WangJianjun Liu Original Article 02 February 2021 Pages: 2970 - 2977
Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis Ian Leigh AlbertsSvenja Elizabeth SeideAli Afshar-Oromieh Original Article Open access 06 February 2021 Pages: 2978 - 2989
Value of integrated PET-IVIM MRI in predicting lymphovascular space invasion in cervical cancer without lymphatic metastasis Chen XuYang YuHongzan Sun Original Article 27 January 2021 Pages: 2990 - 3000
Hemichorea induced by non-ketotic hyperglycemia evaluated with 18F-FDG and 11C-CFT PET/CT Shuilin ZhaoShuang WuMei Tian Image of the Month 13 February 2021 Pages: 3001 - 3002
Urachal remnant metastasis detected on [68Ga] PSMA-11 PET/CT in an asymptomatic prostate cancer patient with biochemical recurrence Jeeban Paul DasAndreas G WibmerHeiko Schöder Image of the Month 18 February 2021 Pages: 3003 - 3004
The superiority of [68Ga]Ga-FAPI-04 over [18F]-FDG in a case of neuroendocrine tumour with hepatic metastasis Hao WangZunguo DuWenwei Zhu Image of the Month 23 February 2021 Pages: 3005 - 3006
Pitfalls in PSMA imaging: [18F]rhPSMA-7-PET/CT reveals presence of chrondrosarcoma B. FeuereckerC. MoglerM. Krönke Image of the Month Open access 25 February 2021 Pages: 3007 - 3008
[18F]FES uptake in the pituitary gland and white matter of the brain R. IqbalC. W. Menke-van der Houven van OordtJ. Booij Image of the Month Open access 17 March 2021 Pages: 3009 - 3010
[153Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma Clemens KratochwilFrederik L. GieselUwe Haberkorn Image of the Month Open access 17 March 2021 Pages: 3011 - 3013
Correction to: Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis Ian Leigh AlbertsSvenja Elizabeth SeideAli Afshar-Oromieh Correction Open access 22 March 2021 Pages: 3014 - 3016